- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01459068
Mental Health Assessment Project on the Thailand-Burma Border (MHAP)
Study of Effectiveness of Mental Health Interventions Among Torture Survivors on the Thailand-Burma Border
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study is part of an award by the USAID Victims of Torture Fund (USAID/VTF) to JHU to work with local and international organizations serving survivors of torture and systematic violence. For this study, the intent is to assist in the design, implementation, monitoring, and evaluation of programming to understand and address the psychosocial needs of Burmese displaced across the Thai/Burma border who are living in the area of Mae Sot, Tak Province in Thailand. Specifically this project involves collaboration with the Burma Border Projects (BBP), the Mae Tao Clinic (MTC), the Assistance Association for Political Prisoners (AAPP), and Social Action for Women (SAW), to help improve the quality and effectiveness of psychosocial and mental health programs.
The Common Elements Treatment Approach (CETA) is a transdiagnostic treatment approach developed for delivery by lay counselors in low and middle income countries (LMIC) with few mental health professionals. CETA was designed to treat symptoms of common mental health disorders including depression, PTS, and anxiety, and to provide skills to deal with life stressors. includes engagement, psychoeducation, anxiety management strategies, behavioral activation, cognitive coping/restructuring, imaginal gradual exposure, suicide/homicide/danger assessment and planning, and screening and brief intervention for alcohol.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Tak Province
-
Mae Sot, Tak Province, Thailand
- Assistance Association for Political Prisoners; Mae Tao Clinic; Social Action for Women
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Burmese national, 18 or over, living in Thailand outside of refugee camps, meets or exceed the algorithm for the Hopkins Symptoms Checklist 25 (HSCL-25) depression subscale and/or the algorithm for the Harvard Trauma Questionnaire (HTQ) posttraumatic stress scale.
Exclusion Criteria:
- not Burmese national, under 18, not living in Thailand outside of refugee camps, does not meet meet or exceed the algorithm for the Hopkins Symptoms Checklist 25 (HSCL-25) depression subscale and/or the algorithm for the Harvard Trauma Questionnaire (HTQ) posttraumatic stress scale; active psychosis
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Waitlist-Control
Eligible study subjects were assigned to the waitlist-control arm on a rolling admissions basis.
The waitlist-controls waited for a period equivalent to the duration of the intervention and then were re-interviewed.
|
|
|
Experimental: Common Elements Treatment Approach
Eligible study subjects randomized into the CETA intervention were offered ten weeks of counseling sessions, consisting of nine elements designed to treat symptoms of common mental health disorders including depression, PTS, and anxiety and to provide skills to deal with life stressors.
|
CETA components include:
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depression
Time Frame: 10-16 weeks
|
Depression symptoms were measured using a modified, locally validated version of the 15-item Hopkins Symptoms Checklist (HSCL-25) depression subscale.
Respondents reported symptom frequency in the last month (0 "None of the time" to 3 "Almost always").
An algorithm was applied to the HSCL-25 to determine eligibility on the basis of moderate to severe depression.
The HSCL-25 was also used to measure the depression severity outcome: Scores on the depression scale were calculated as average symptom scores across the 17 items and therefore ranged from 0-3
|
10-16 weeks
|
|
Posttraumatic Stress Symptoms
Time Frame: 10-16 weeks
|
Posttraumatic stress symptoms (PTSS) were measured using the 30-symptom items of the Harvard Trauma Questionnaire (HTQ).
Response options were the same as the HSCL-25.
An algorithm was applied to the HTQ to determine eligibility on the basis of moderate to severe PTSS.
The HTQ was also used to measure the PTSS severity outcome: Scores for PTSS were calculated as average symptom scores across the 30 items.
PTSS scores ranged from 0 (best possible outcome) to 3 (worst possible outcome).
|
10-16 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional Impairment
Time Frame: 10-16 weeks
|
Functional impairment was measured using locally-developed, gender-specific scales.
The scales contained 16 and 23 tasks for men and women, respectively.
Respondents reported current difficulty compared to others of same gender and similar age (from 0 "No difficulty" to 4 "Often cannot do").
Scores were calculated as average task scores across the 16- and 23-item scales and therefore ranged from 0-4
|
10-16 weeks
|
|
Anxiety Symptoms
Time Frame: 10-16 weeks
|
Anxiety symptoms were measured using the 10-item HSCL-25 anxiety subscale with local adaptations.
Respondent instructions and response categories were the same as the HSCL-25 depression subscale.
Scores were calculated as average symptom scores across the 11-item scale and therefore ranged from 0-4
|
10-16 weeks
|
|
Aggression Behaviors
Time Frame: 10-16 weeks
|
The 12-item Aggression Questionnaire (AQ) was adapted for local use.
Respondents rated frequency in general of aggressive behaviors from 0 "None of the time" to 4 "Almost all of the time."
Scores were calculated as averages scores for each behavior across the 12-item scale and therefore ranged from 0-4
|
10-16 weeks
|
|
Alcohol Use
Time Frame: 10-16 weeks
|
Alcohol use was measured using the Alcohol Use Disorders Identification Test (AUDIT).
Respondents reported frequency and amount of alcohol consumed, referencing photographs of local alcohols (local beers, rice whiskeys, etc.).
Total scores were calculated as sum totals across the 10-item scale.
AUDIT total scores ranged from 0 (best possible outcome) to 40 (worst possible outcome).
|
10-16 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Courtland Robinson, PhD, Johns Hopkins Bloomberg School of Public Health
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00003601
- DFD-A-00-08-00308-0 (Other Identifier: USAID)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
Fondation FondaMentalGYNOVNot yet recruitingDepression | Depression in Adults | Depression DisorderFrance
Clinical Trials on Common Elements Treatment Approach
-
International Rescue CommitteeJohns Hopkins University; Khon Kaen UniversityRecruitingEpilepsy | Hypertension | Diabetes | Medication Adherence | Self Efficacy | Mental Health IssueThailand
-
Johns Hopkins Bloomberg School of Public HealthNational Institute of General Medical Sciences (NIGMS); Native American Research...Completed
-
Michael J Mugavero, MDUniversity of North Carolina, Chapel HillCompletedDepression | HIV/AIDS | Anxiety | Substance Use Disorders | Post-traumatic Stress DisorderUnited States
-
Johns Hopkins Bloomberg School of Public HealthUnited States Agency for International Development (USAID)CompletedDepression | PostTraumatic Stress DisorderUkraine
-
Johns Hopkins Bloomberg School of Public HealthUnited States Agency for International Development (USAID)TerminatedChild Mental Disorder | Behavior ProblemMyanmar
-
University of Illinois at ChicagoNational Institute on Minority Health and Health Disparities (NIMHD); Sinai...Not yet recruitingDepression | Anxiety | Traumatic Stress
-
Queen Mary University of LondonJohns Hopkins University; American University of Beirut Medical Center; Medical... and other collaboratorsCompletedDepression | PTSD | Anxiety | Conduct Disorder | Oppositional Defiant DisorderLebanon
-
Columbia UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); University of Alabama... and other collaboratorsTerminatedDepression | HIV/AIDS | Substance Use Disorders | Alcohol Use Disorder | Post-traumatic Stress DisorderZambia
-
Universidad del Valle, ColombiaJohns Hopkins Bloomberg School of Public Health; United States Agency for International... and other collaboratorsCompletedDepression | Anxiety | Post-Traumatic Stress Disorder | ViolenceColombia
-
University of Alabama at BirminghamNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Active, not recruitingHiv | Alcohol ProblemUnited States